Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet

Shares of Rhythm Pharmaceuticals, Inc. (RYTM) have gained 0.3% over the past four weeks to close the last trading session at $56.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $71.42 indicates a potential upside of 26.4%.The mean estimate comprises 12 short-term price targets with a standard deviation of $6.87. While the lowest estimate of $60 indicates a 6.2% increase from ...